Granular Machine Learning-Based Computed Tomography Contrast Phase Prediction
Mayo Clinic Proceedings: Digital HealthResearch Authors: S Moein Rassoulinejad-Mousavi, Bardia Khosravi, Alex D Weston, Ryan T Moerer, Aaron E Carretero Benites, Hillary W Garner, Naoki Takahashi, Timothy L Kline, Michael F Romero, John C Lieske, Bradley J EricksonAIIM Authors: Akshita Nigam, Madison SchanzApproved by President Reda RiffiPublication Date: 12/19/2025Comprehensive Summary
The study conducted by Rassoulinejad-Mousavi et al. covers the development of a machine learning framework designed to automate the detection of intravenous contrast and the classification of eight granular renal contrast phases in abdominal CT scans. The researchers used a retrospective dataset of 3,033 CT scans to train a hybrid model consisting of a ConvNeXt-Femto deep learning (DL) architecture for feature extraction and a Random Forest (RF) regressor to predict different stages. The study found that the DL classifier achieved 100% accuracy in detecting the presence of contrast, while the hybrid DL+RF model outperformed DL models in predicting specific phases, achieving an absolute accuracy of 79.25% and near-perfect agreement with other radiologists. The authors conclude that this framework successfully reduces inter-rater variability and provides a scalable solution for precise and automated characterizations of renal enhancement phases.
Outcomes and Implications
This research is important because precise phase identification is crucial for accurate tumor staging, surgical planning, and distinguishing between renal cell carcinoma subtypes. This work applies to medicine by providing an automated tool that ensures there is diagnostic consistency in supporting the validity of imaging biomarkers across large datasets. While a specific date for widespread rollout is not provided, the authors note the framework is already robust enough for internal-external clinical validation and could immediately serve as a quality control tool.
Connect medicine with AI innovation.
No spam. Only the latest AI breakthroughs, simplified and relevant to your field.